Support PenkeX4 Pharmaceuticals Inc - Trending symbols
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-04-17 |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt | -41,185 | 38,967 | -2,218 | -66,772 | -68,990 | 49,781 | -19,209 | 41,596 | 22,387 | |
| Total Other Income Expense Net | -1,104 | -1,005 | -2,109 | -1,463 | -3,572 | -2,698 | -6,270 | 12,703 | 6,433 | |
| Net Receivables | 393 | 169 | 562 | 140 | 702 | 152 | 854 | -5,331 | -4,477 | |
| Income before Tax | -55,697 | 53,418 | -2,279 | -16,818 | -19,097 | -32,650 | -51,747 | 142,598 | 90,851 | |
| Net Income | -55,712 | 53,407 | -2,305 | -16,825 | -19,130 | -32,636 | -51,766 | 142,599 | 90,833 | |
| Net Income from Continuing Operations | -55,712 | 53,407 | -2,305 | -16,825 | -19,130 | -32,636 | -51,766 | 142,599 | 90,833 | |
| Gross Profit | -516 | 14 | -502 | 440 | -62 | 0 | -62 | 357 | 295 | |
| Depreciation and Amortization | 155 | 7,645 | 7,800 | -7,449 | 351 | 19,165 | 19,516 | -20,534 | -1,018 | |
| Tax Provision | 2 | 1 | 3 | 20 | 23 | -19 | 4 | -17 | -13 | |
| Income Tax Expense | 2 | 1 | 3 | 20 | 23 | -19 | 4 | -17 | -13 |
Comments
How you think about this?